FDA Crackdown and Oral Ozempic Launch Set Stage for Earnings
Novo Nordisk enters a pivotal week with an FDA shortage-list victory, oral Ozempic rollout, and partnerships to capture…
FDA Curbs Copycats as Oral Ozempic Hits 70,000 Pharmacies
Novo Nordisk gains 6% as FDA targets cheap semaglutide copies and launches first oral GLP-1 tablet in the…